Ratio of earnings before interest, taxes, depreciation, and amortization to sales for private limited companies in the pharmaceuticals and medicines manufacturing industry

Annual · percent · 2010–2012 · Published by India — Reserve Bank of India

Latest · 2012

13.3%

down −1.5 pts vs 2011

High since 2010
14.8% · 2011
Low since 2010
12.7% · 2010

percent

Use this series in your AI

Use FactIQ to chart rbi::rbi|02c575150f3848f9 over the last ten years, with its latest value and the change over the past year.

Paste into an AI model with FactIQ connected. How to connect

About this series

This series represents the EBITDA to sales ratio, a key profitability metric, for non-government non-financial private limited companies operating within the pharmaceuticals and medicines subgroup of the manufacturing sector. The data is derived from financial ratios of select items for the 2012-13 fiscal year snapshot. (Footnote: Note : 1. Figures in brackets below the industry name represent the number of companies in the industry. 2. For footnotes, please refer to Statement 2 and Statement 7. 3. Industry group, viz., 'Basic Chemicals' and 'Pharmaceuticals & Medicines' are subgroup of 'Chemical and Chemical Products'. 4. Industry group, viz., 'Plastic Products' is the subgroup of 'Rubber and Plastic Products'.)

Series ID
rbi::rbi|02c575150f3848f9
Frequency
Annual
Units
percent
Coverage
2010 – 2012
Ratio of earnings before interest, taxes, depreciation, and amortization to sales for private limited companies in the pharmaceuticals and medicines manufacturing industry: 13.3% for 2012 · FactIQ